JP2024508709A5 - - Google Patents
Info
- Publication number
- JP2024508709A5 JP2024508709A5 JP2023548578A JP2023548578A JP2024508709A5 JP 2024508709 A5 JP2024508709 A5 JP 2024508709A5 JP 2023548578 A JP2023548578 A JP 2023548578A JP 2023548578 A JP2023548578 A JP 2023548578A JP 2024508709 A5 JP2024508709 A5 JP 2024508709A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- antibody according
- chain
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150488P | 2021-02-17 | 2021-02-17 | |
| US63/150,488 | 2021-02-17 | ||
| US202163249455P | 2021-09-28 | 2021-09-28 | |
| US63/249,455 | 2021-09-28 | ||
| PCT/US2022/016683 WO2022178047A1 (en) | 2021-02-17 | 2022-02-17 | Anti-cd123 binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024508709A JP2024508709A (ja) | 2024-02-28 |
| JP2024508709A5 true JP2024508709A5 (https=) | 2025-02-21 |
Family
ID=82931699
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548578A Pending JP2024508709A (ja) | 2021-02-17 | 2022-02-17 | 抗ｃｄ１２３結合分子及びその使用法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240076392A1 (https=) |
| EP (1) | EP4294829A4 (https=) |
| JP (1) | JP2024508709A (https=) |
| KR (1) | KR20230146022A (https=) |
| AU (1) | AU2022221633A1 (https=) |
| CA (1) | CA3205834A1 (https=) |
| IL (1) | IL304485A (https=) |
| MX (1) | MX2023009615A (https=) |
| WO (1) | WO2022178047A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3560954T3 (pl) | 2014-04-03 | 2021-12-13 | Igm Biosciences, Inc. | Zmodyfikowany łańcuch J |
| IL308212A (en) | 2015-01-20 | 2024-01-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| EP3355913B1 (en) | 2015-09-30 | 2024-10-30 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
| EP3356401B1 (en) | 2015-09-30 | 2020-06-24 | IGM Biosciences, Inc. | Binding molecules with modified j-chain |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9573988B2 (en) * | 2013-02-20 | 2017-02-21 | Novartis Ag | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells |
| WO2014138306A1 (en) * | 2013-03-05 | 2014-09-12 | Baylor College Of Medicine | Engager cells for immunotherapy |
| EP3957738A1 (en) * | 2015-03-04 | 2022-02-23 | IGM Biosciences, Inc. | Cd20 binding molecules and uses thereof |
| TWI790206B (zh) * | 2016-07-18 | 2023-01-21 | 法商賽諾菲公司 | 特異性結合至ｃｄ３和ｃｄ１２３的雙特異性抗體樣結合蛋白 |
| CN109952112B (zh) * | 2016-09-21 | 2024-09-06 | 阿帕特夫研究和发展有限公司 | Cd123结合蛋白和相关的组合物和方法 |
| BR112019010061A2 (pt) * | 2016-11-16 | 2019-08-13 | Ablynx Nv | polipeptídeos de recrutamento de células t capazes de se ligarem ao cd123 e tcr alfa/beta |
| MX2019011986A (es) * | 2017-04-07 | 2019-11-07 | Igm Biosciences Inc | Regiones constantes de igm humana modificadas para la modulacion de la funcion efectora de la citolisis dependiente de complemento referencia cruzada a solicitudes relacionadas. |
| KR20200041834A (ko) * | 2017-06-01 | 2020-04-22 | 젠코어 인코포레이티드 | Cd123 및 cd3에 결합하는 이중특이성 항체 |
| MX2020009069A (es) * | 2018-03-01 | 2020-10-08 | Igm Biosciences Inc | Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero. |
| EP3853254A1 (en) * | 2018-09-20 | 2021-07-28 | Lentigen Technology, Inc. | Compositions and methods for treating cancer with anti-cd123 immunotherapy |
| JP2022532868A (ja) * | 2019-05-04 | 2022-07-20 | インヒブルクス インコーポレイテッド | Ｃｄ１２３結合性ポリペプチド及びその使用 |
| KR20220045030A (ko) * | 2019-08-17 | 2022-04-12 | 아이쥐엠 바이오사이언스 인코포레이티드 | 다량체성 이중특이적 항-cd123 결합 분자 및 이의 용도 |
-
2022
- 2022-02-17 US US18/261,145 patent/US20240076392A1/en active Pending
- 2022-02-17 EP EP22756876.3A patent/EP4294829A4/en active Pending
- 2022-02-17 AU AU2022221633A patent/AU2022221633A1/en active Pending
- 2022-02-17 JP JP2023548578A patent/JP2024508709A/ja active Pending
- 2022-02-17 WO PCT/US2022/016683 patent/WO2022178047A1/en not_active Ceased
- 2022-02-17 KR KR1020237027352A patent/KR20230146022A/ko active Pending
- 2022-02-17 MX MX2023009615A patent/MX2023009615A/es unknown
- 2022-02-17 CA CA3205834A patent/CA3205834A1/en active Pending
-
2023
- 2023-07-16 IL IL304485A patent/IL304485A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024508709A5 (https=) | ||
| JP7411316B2 (ja) | 三重特異性結合タンパク質と使用方法 | |
| JP2020063262A5 (https=) | ||
| RU2558301C2 (ru) | Полипептиды для связывания с "рецептором конечных продуктов гликирования", а также их композиции и способы, в которых они принимают участие | |
| JP2021502810A5 (https=) | ||
| JP2019196365A5 (https=) | ||
| CN111423512B (zh) | 阻断血管内皮细胞生长且活化t细胞的多靶向融合蛋白和包含其的药物组合物 | |
| JP2022545655A5 (https=) | ||
| CA2798390A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies | |
| JP2020508068A5 (https=) | ||
| KR20200123782A (ko) | 암치료를 위해 화학치료제와 병용된 다중결합 항-dr5 결합분자의 용도 | |
| JP2013527761A5 (https=) | ||
| JP6242484B2 (ja) | 特定の改善されたヒト二重特異性ＥＧＦＲｖＩＩＩ抗体結合分子 | |
| JP2018504092A5 (https=) | ||
| JP2007532139A5 (https=) | ||
| AR039067A1 (es) | Anticuerpos para cd40 | |
| JP2020521478A5 (https=) | ||
| RU2013134983A (ru) | Рекомбинантные антитела против фактора роста эндотелия сосудов (vegf), полученные посредством мутагенеза вариабельной области | |
| JP2023544143A5 (https=) | ||
| JP2025128343A5 (https=) | ||
| JP2010500006A5 (https=) | ||
| KR20230141817A (ko) | 이중특이 항체 | |
| JP2024507693A5 (https=) | ||
| JP2015520172A5 (https=) | ||
| JP2022523360A5 (https=) |